Pathogen Adherence to Carbohydrate Database (PACDB)

PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.

Database Last Updated
Pathogen Adherence to Carbohydrate Database (PACDB) June 1, 2016
Species Pathogen Adherence Molecule Ligand Name Ligand Feature Target Source Glycan Sequence Binding ▲ PubMed ID
Cholera toxin
Asialo GM1 (Gangliotetraosylceramide; Gg4; GA1)
Oligoglycosylceramides
Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Shiga toxin
SSEA-3 (GSL) (Galactosyl globoside; Gb5)
Oligoglycosylceramides
Gal(b1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Shiga toxin
unnamed ligand
Oligoglycosylceramides
[Gal(a1-3)]nGal(a1-4)Gal(b1-4)Glc(b1-1)Cer *n=2-5
Not Binding
Tetanus toxin
Asialo GM1 (Gangliotetraosylceramide; Gg4; GA1)
Oligoglycosylceramides
Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Unknown
Asialo GM1 (Gangliotetraosylceramide; Gg4; GA1)
Oligoglycosylceramides
Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Unknown
Asialo GM1 (Gangliotetraosylceramide; Gg4; GA1)
Oligoglycosylceramides
Gal(b1-3)GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
PsaA/B (pH-6 antigen)
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH)
Oligoglycosylceramides
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
(class III)
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH)
Oligoglycosylceramides
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Lectin-like proteins (adhesin)
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH)
Oligoglycosylceramides
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Unknown
Gb3 (Globotriaosylceramide; Trihexosylceramide; Pk antigen (GSL); CTH)
Oligoglycosylceramides
Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
Not Binding
Displaying entries 1811 - 1820 of 1840 in total

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01